featured
Leptomeningeal Enhancement Under Different MS Immunotherapies
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Multiple Sclerosis (Houndmills, Basingstoke, England)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Leptomeningeal enhancement under different MS immunotherapies: A monocentric retrospective cohort study of 214 patients
Mult. Scler. 2022 Sep 15;2022(0)13524585221122210, F Christoph, W Franca, H Helly Noemi, K Nicole, W Roland, D Lara, C Andrew, S Anke, H RobertFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.